ABVC BioPharma, Inc. (ABVC) vs Estrella Immunopharma, Inc. (ESLA)

A side-by-side comparison of ABVC BioPharma, Inc. and Estrella Immunopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
ABVC BioPharma, Inc. logo
ABVC
ABVC BioPharma, Inc.
$25M
$0.98HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Estrella Immunopharma, Inc. logo
ESLA
Estrella Immunopharma, Inc.
$19M
$0.44HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ABVC vs ESLA

growth of $100 · dividends reinvested · last 5y
ABVC -97.1% (-50.8%/yr)ESLA -95.5% (-46.2%/yr)ESLA compounded faster over this window
050100150Start $10020222023202420252026$3$5
ABVC ESLA

ABVC vs ESLA: by the numbers

  • •ABVC is the larger company ($25M vs $19M market cap).

Metrics side by side

Valuation

MetricABVCESLA
P/B ratio2.48N/A

Profitability

MetricABVCESLA
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-76.82%N/A
ROIC-53.34%N/A

Growth (annualized)

MetricABVCESLA
Total return CAGR (5Y)-46.33%-46.34%

Go deeper

Full ABVC analysisFull ESLA analysisInteractive comparison tool

Dig into the metrics

ABVC BioPharma ROEEstrella Immunopharma ROEABVC BioPharma operating marginEstrella Immunopharma operating marginABVC BioPharma revenue growthEstrella Immunopharma revenue growthABVC BioPharma free cash flowEstrella Immunopharma free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.